Schedule 13D David W. Moskowitz
OMB APPROVAL
OMB Number: 3235-0145
Expires: October 31, 2002
Estimated average burden
hours per response. . . 14.9
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. _____)*
GENOMED, INC.
(Name of Issuer)
Common stock
(Title of Class of Securities)
37243C102
(CUSIP Number)
Brenda Lee Hamilton, Esquire
Hamilton, Lehrer & Dargan, P.A.
2 East Camino Real, Suite 202
Boca Raton Florida 33432
Telephone: 561-416-8956
Facsimile: 561-416-2855
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
AUGUST 22, 2002
(Date of Event which Requires Filing of this Statement)
CUSIP No. 37243C102
--------------------------------------------------------------------------------
1. Names of Reporting Persons. I.R.S. Identification Nos. of
above persons (entities only).
DAVID W. MOSKOWITZ
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) NOT APPLICABLE
(b) NOT APPLICABLE
--------------------------------------------------------------------------------
3. SEC Use Only
..............................................................
--------------------------------------------------------------------------------
4. Source of Funds (See Instructions)
OO - THE SHARES WERE ISSUED TO DR. MOSKOWITZ AS THE SOLE OWNER
OF GENOMIC MEDICINE, LLC IN ACCORDANCE WITH THE TERMS OF THE
AGREEMENT AND PLAN OF SHARE EXCHANGE BETWEEN THE ISSUER AND
GENOMIC MEDICINE, LLC IN WHICH THE ISSUER ACQUIRED 100% OF
GENOMIC MEDICINE, LLC.
--------------------------------------------------------------------------------
5. Check if Disclosure of Legal Proceedings Is Required Pursuant
to Items 2(d) or 2(e)
NOT APPLICABLE
--------------------------------------------------------------------------------
6. Citizenship or Place of Organization
UNITED STATES
--------------------------------------------------------------------------------
Number of 7. Sole Voting Power............. 12,500,000 Shares
Shares ------------------------------------------------------
Beneficially 8. Shared Voting Power ...............0
Owned by ------------------------------------------------------
Each 9. Sole Dispositive Power........ 12,500,000 Shares
Reporting ------------------------------------------------------
Person With 10. Shared Dispositive Power ..........0
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by
Each Reporting Person ................... 12,500,000 Shares
--------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain
Shares (See Instructions)
NOT APPLICABLE
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
10.7%
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
IN
--------------------------------------------------------------------------------
Item 1. Security and Issuer
COMMON STOCK OF GENOMED, INC.
155 CLAYTON AVENUE
ST. LOUIS, MO 63110
Item 2. Identity and Background
(a) DAVID W. MOSKOWITZ
(b) DR. MOSKOWITZ'S BUSINESS ADDRESS IS 450 CLAYTON AVENUE, ST.
LOUIS, MO 63110.
(c) DR. MOSKOWITZ IS THE CHIEF MEDICAL OFFICER, TREASURER AND
CHAIRMAN OF THE BOARD OF ISSUER.
(d) DR. MOSKOWITZ HAS NOT BEEN CONVICTED IN A CRIMINAL PROCEEDING IN
THE LAST FIVE YEARS.
(e) DR. MOSKOWITZ HAS NOT BEEN A PARTY TO A CIVIL PROCEEDING OF A
JUDICIAL OR ADMINISTRATIVE BODY OF COMPETENT JURISDICTION IN THE
LAST FIVE YEARS.
(f) DR. MOSKOWITZ IS A CITIZEN OF THE UNITED STATES.
Item 3. Source and Amount of Funds or Other Consideration - THE 12,500,000
SHARES WERE ISSUED TO DR. MOSKOWITZ AS THE SOLE OWNER OF GENOMIC MEDICINE, LLC
IN ACCORDANCE WITH THE TERMS OF THE AGREEMENT AND PLAN OF SHARE EXCHANGE BETWEEN
THE ISSUER AND GENOMIC MEDICINE, LLC IN WHICH THE ISSUER ACQUIRED 100% OF
GENOMIC MEDICINE, LLC.
Item 4. Purpose of Transaction - THE 12,500,000 SHARES WERE ISSUED TO DR.
MOSKOWITZ AS THE SOLE OWNER OF GENOMIC MEDICINE, LLC IN ACCORDANCE WITH THE
TERMS OF THE AGREEMENT AND PLAN OF SHARE EXCHANGE BETWEEN THE ISSUER AND GENOMIC
MEDICINE, LLC IN WHICH THE ISSUER ACQUIRED 100% OF GENOMIC MEDICINE, LLC.
Item 5. Interest in Securities of the Issuer
(a) THE AGGREGATE NUMBER AND PERCENTAGE OF COMMON STOCK BENEFICIALLY
OWNED BY DR. MOSKOWITZ IS 12,500,000 SHARES AND 10.7%,
RESPECTIVELY.
(b) DR. MOSKOWITZ HAS THE SOLE POWER TO VOTE ALL 12,500,000 SHARES
HE OWNS.
(c) THERE ARE NO TRANSACTIONS REGARDING COMMON STOCK THAT WERE
EFFECTED DURING THE LAST SIXTY DAYS BY DR. MOSKOWITZ.
(d) NO OTHER PERSON IS KNOWN TO HAVE THE RIGHT TO RECEIVE OR THE
POWER TO DIRECT THE RECEIPT OF DIVIDENDS FROM, OR THE PROCEEDS
FROM THE SALE OF, THE SECURITIES.
(e) DR. MOSKOWITZ HAS NOT CEASED TO BE THE BENEFICIAL OWNER OF MORE
THAN FIVE PERCENT OF COMMON STOCK.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer - NOT APPLICABLE.
Item 7. Material to Be Filed as Exhibits - NOT APPLICABLE.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Date - September 10, 2002
Signature - /s/David W. Moskowitz
Name/Title - David W. Moskowitz, Chief Medical Officer/Treasurer
/Chairman of the Board